Pharmaceutical Industry an overview

Submitted to : Prof. S. Mohan Anuj Parasar MS12V005

Contents
Brief History of Pharmaceutical Industries Major Development in Pharma in India Current Scenario Success Stories of Indian Pharmaceutical global acquisition Indian Pharma Potential Benefit by upcoming patent expiry SWOT analysis of Pharma sector

Major Challenges References

Brief History of Pharmaceutical Industries

Prior to 20th century In 1640 BC Acharya Dhanvantari wrote a treatise on Medicine & surgery. Acharya Sushrutha & Charaka contributed in Ayurvedic medicine. Modern day Allopathic Medication is around 350 years old. 1900~1970.. In 1901 Acharya P.C. Ray started first Indian Pharma company. In 1930 Penicillin & Insulin were discovered. In 1970s Product patent was replaced by process patent

Major Development in Pharma in India

1970~1980.. 1970s saw the emergence of Indian Pharmaceutical Industry. During 1970-80s New products in the Cardio Vascular, Neuro, Psycho-somatic, Gastro Renal, Anti Fungal and Anti Inflammatory segments launched During this period export of Bulk Drugs to Asia, Africa , Europe and Latin America also started. More and more organization were able to certify to USFDA & WHO GMP standards

Current Scenario
Present global market size is $825 billion growing @ 4-6% per year. India is 3rd largest producer of Pharmaceuticals having 10% of the global share. The Indian Pharmaceutical market is expected to touch $74 billion sales by 2020 from present $11 billion.

Success Stories of Indian Pharma Companies : Global Acquisitions

Indian Pharma Potential Benefit by upcoming patent expiry

Indian Pharmaceutical Industry-SWOT Analysis

S
World-class process development labs Excellent clinical trial centres Chemical and process development competencies

W
Low R&D investments Absence of association between institutes and industry Production of duplicate drugs

O
Incredible export potential Increasing health consciousness

T
Competition from MNCs Outdated Sales and marketing methods

Major Challenges
Declining productivity of in house R&D. Increasing legal and regulatory concern Quality management : Conformance to global standard (USFDA,HACCP,CGMP)

References
www.kpmg.com www.icra.com